SIRT1 and ischemia: Nicotinamide phosphoribosyltransferase (Nampt, also known as visfatin), the rate-limiting enzyme in mammalian NAD+ biosynthesis (Wang et al., 2012), plays several roles in protecting against ischemia, one of which was associated with the Nampt-Sirt1-AMPK neuroprotective signaling pathway.